Equity Details
Price & Market Data
Price: $71.75
Daily Change: +$1.66 / 2.31%
Daily Range: $69.51 - $71.89
Market Cap: $3,941,481,216
Daily Volume: 1,006,734
Performance Metrics
1 Week: 24.59%
1 Month: 11.10%
3 Months: 7.52%
6 Months: 42.22%
1 Year: 58.63%
YTD: 16.61%
About LivaNova PLC (LIVN)
Stay updated on LivaNova PLC (LIVN). Price: 71.75, daily change: +$1.66 / 2.31%. Market cap: 3,941,481,216. Performance YTD, 1-week, and 52-week are key.
Company Details
Employees: 3300
Sector: Health technology
Industry: Medical specialties
Country: United Kingdom
Details
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and difficult-to-treat depression. This segment also includes the development and clinical testing of LivaNova's aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, and other healthcare professionals, hospitals, and other medical institutions and healthcare providers. The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.